Post-earnings recap
Reported
Mon, Apr 11, 2022
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
0%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
CytoDyn Inc. reported a loss of $0.05 per share, but did not provide revenue figures. The stock reacted negatively, dropping 8.23%. The lack of guidance and commentary from management may have contributed to investor uncertainty.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.05 | N/A | — |
| Revenue | — | N/A | — |
No transcript is on record for this earnings call, so the analysis is based solely on numerical results.